Last reviewed · How we verify
NCT07386015
Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
trial testing Observational Data Collection in Freezing of Gait in 700 participants. Currently enrolling.
31 December 2029
Quick facts
| Lead sponsor | Tianjin Huanhu Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 700 |
| Start date | 28 February 2026 |
| Primary completion | 31 December 2029 |
| Estimated completion | 30 November 2030 |
| Sites | 1 location across China |
Drugs / interventions tested
- Observational Data Collection
Conditions studied
- Freezing of Gait — all drugs for Freezing of Gait →
- Parkinson's Disease — all drugs for Parkinson's Disease →
- Parkinsonism — all drugs for Parkinsonism →
- Vascular Parkinsonism — all drugs for Vascular Parkinsonism →
Sponsor
Tianjin Huanhu Hospital
Who can join
Adults 30 to 85, any sex, with Freezing of Gait or Parkinson's Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a prospective, multicenter, observational cohort (patient registry) designed to better understand freezing of gait (FOG), a disabling walking problem that can occur in Parkinson's disease and other related neurological conditions.The purpose of this registry is to collect long-term clinical information from patients with freezing of gait or gait and balance problems, and to explore how different causes of FOG are related to symptoms, walking patterns, falls, disease progression, and outcomes over time. The study will include participants with Parkinson's disease and other conditions associated with freezing of gait.Participants will receive standard medical care as determined by their treating physicians. No experimental drugs or study-related treatments will be assigned as part of this registry. Clinical information will be collected during routine visits and follow-up assessments, including questionnaires, walking and balance evaluations, video recordings, and other commonly used clinical tests.The information collected in this study may help improve the understanding of freezing of gait, support better risk assessment for falls, and guide future research and clinical management strategies for patients with gait and balance disorders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07386015
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observational Data Collection
Trials testing the same drug.
- NCT06866678 — Frailty Score and Postoperative Morbidity in Colorectal Cancer Surgery · completed
- NCT03114436 — National Observational Study of Clinical Practices in Deceased Organ Donation · completed
Other recruiting trials for Freezing of Gait
Currently open trials in the same condition.
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07316296 — Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi · Phase 3 · recruiting
- NCT06713265 — Study of the Link Between Freezing of Gait and Oropharyngeal Freezing in Parkinson's Patients · recruiting
- NCT06630702 — Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease · NA · recruiting
- NCT06316232 — DBS and Levodopa for Treating Freezing of Gait in Parkinson's Disease · Phase 4 · recruiting
Other Tianjin Huanhu Hospital trials
Trials by the same sponsor.
- NCT07365475 — Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke · Phase 2 · not yet recruiting
- NCT07294391 — The Preliminary Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic St · Phase 2 · not yet recruiting
- NCT07115511 — Combined Recanalization Therapy for Acute Large Vessel Occlusion Stroke · NA · recruiting
- NCT06621121 — A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Strok · recruiting
- NCT06967025 — Ischemic Postconditioning in Acute Stroke Patients Receiving Endovascular Thrombectomy · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07386015 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin Huanhu Hospital
- Last refreshed: 10 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07386015.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing